Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
24 Jul 2025 |
On P&L |
The Company releases the press release related to the first half of 2025 financial results
|
Download |
|
24 Jul 2025 |
On P&L |
The Company releases the first half 2025 financial results presentation
|
Download |
|
25 Mar 2025 |
On business and financial situation |
The Company releases the presentation related to its strategy update because of its 2025 Capital Markets Day
|
Download |
|
25 Feb 2025 |
On P&L |
The Company releases the press release related to the full year 2024 financial results
|
Download |
|
25 Feb 2025 |
On P&L |
The Company releases the full year 2024 financial results presentation
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
27 Jul 2022 |
On business and financial situation |
The Company releases the press release related to the first half 2022 financial results
|
Download |
|
27 Jul 2022 |
On business and financial situation |
The Company releases the first half 2022 financial results presentation
|
Download |
|
04 Jul 2022 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the second quarter of 2022
|
Download |
|
30 Jun 2022 |
Other relevant information |
The Company informs about the dividends payment
|
Download |
|
16 Jun 2022 |
Other relevant information |
The Company has agreed to execute the capital reduction approved by the 2022 Ordinary General Meeting to amortize the shares acquired in the framework of the own shares repurchase programs
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Jan 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the fourth quarter of 2017
|
Download |
|
21 Dec 2017 |
Préstamos, créditos y avales |
ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the press release related to the nine-month period ended 30 September 2017 results
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the presentation related to the nine-month period ended 30 September 2017 results.
|
Download |
|
24 Oct 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project.
|
Download |
Pages
